SlideShare ist ein Scribd-Unternehmen logo
1 von 16
Downloaden Sie, um offline zu lesen
ADALIMUMAB
Introduction
• human monoclonal antibody against TNF-alpha
• C6428H9912N1694O1987S46
• organic chemical
• produced by recombinant DNA technology using mammalian cell
expression system
• Adalimumab is used for treatment of rheumatoid arthritis, psoriatic
arthritis, ankylosing spondylitis and Crohn’s disease
• immune system mediated diseases
History
• 1993 - BASF bioresearch and Cambridge Antibody
• 3rd TNF inhibitor approved in United States
• fully human monoclonal
• initially discovered using CAT’s phage display technology and being
named as D2E7
• BASF bioresearch Corporation – create
• Abbott Laboratories – further manufacturing and marketing
• 2008 - Food and Drug Administration (FDA) approved adalimumab as
treatment of arthritis and Crohn’s disease
• 2012 - FDA approved for treatment of ulcerative colitis
• 2014 - generic drugs of adalimumab has been launched by other
companies
• sold under the trade name, Humira
• rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis,
plaque psoriasis, Crohn’s disease
• tumor necrosis factor-alpha (TNF- α) blocker
How it works?
• directly binding to TNF- α molecules in the blood and diseased tissue
• blocks its interaction with the p55 and p75 cell surface TNF receptors
• lyses surface TNF expressing cells in vitro
• does not bind or inactivate lymphotoxin (TNF-beta)
• Excess production of TNF-alpha - rapid growth of skin cells and
damages to joint tissue
• Adalimumab helps to stop the inflammatory cycle of psoriatic disease
and prevent from causing the inflammation that result in psoriasis
plaques.
Prescription, Pharmacodynamics,
Pharmacokinetics
• prescribed by either itself or in combination with methotrexate
• given after other medications has failed in treatment
• safe to take it with topical treatments or pain relievers
• Adult – decrease acute inflammation, C-reactive protein (CRP),
erythrocyte sedimentation rate (ESR), and serum cytokines (IL-6)
• maximized with the maximum serum concentration
• Tmax were 4.7 ± 1.6 µg/mL and 131 ± 56 hours
• linear over the dose range of 0.5 to 10.0 mg/kg following a single
intravenous dose
efficacy of adalimumab
• phase II randomized placebo-controlled trial evaluate 147 patients
with psoriasis that at least 5% of their (BSA) infected and minimum 10
(PASI)
• Patient had achieved the primary endpoint of PASI 75 or better as
compared to 4% of the patients who received placebo.
• phase II trial is to compare the efficacy of adalimumab to
methotrexate (MTX) and placebo.
• phase III trials were performed to directly compare the therapeutic
efficacy, safety and tolerability and to provide greater body of data
• 80patients given adalimumab, 36% patients given methotrexate and
19% patients given placebo achieving a PASI 75 response rate at a
given time
• (PGA) score :73% in adalimumab, 30% in methotrexate and 11% in
placebo
• second phase III trials was to examine the short- and long-term
efficacy of adalimumab as monotherapy against placebo
• treatment with 40mg adalimumab every other week
• efficacy of adalimumab is sustainable.
• high dose in phase II - Adverse reaction of pain with injection
• headache, nausea, elevated triglycerides, cough, sinus congestion,
and fatigue
• no increase of serious adverse events in phase III trials
• recommended dose of 40 mg every other week, and the higher dose
of 40 mg weekly, either alone or in combination with methotrexate or
other DMARDs
• short- and long-term safety, tolerability and substantial efficacy
Risk
• developing severe and even fatal infections
• Tuberculosis may be caused by a new infection or by reactivation of a
previous infection
• tumor necrosis factor (TNF) blocker - develop Lymphoma and other
types of cancer such as hepatosplenic T-cell lymphoma (HSTCL)
• attempt a TB skin test before taking Adalimumab
• positive result should begin treatment for TB
• negative result should also be monitored for signs of TB while using
adalimumab
Precautions
• Should not drive - dizziness or vision changes
• avoid contact with people who have colds or infections
• should not do any activities that may cause bruising or injury
• should not breastfeed
Side Effects
Common side effect
• back pain, headache, redness or swelling at injection site
• mild stomach pain, nausea or runny nose
Severe side effect
• rash, itching, difficulty in breathing, swelling of lips or tongue, blood
in urine, burning, numbness, chest pain, fainting, blistered, peeling
skin, swelling of ankles, diarrhoea or vomit.
Overdose
• still unclear
• does not show toxic effects in clinical trials
Challenges
• target specific drugs
• specialized drug for individual
• competition of new generic drugs
• Amgen for patenting rights
Conclusion
• fully human monoclonal anti-TNF antibody drug
• treat inflammation and chronic skin condition
• Efficacy of adalimumab is sustainable
• side effect isn’t life threatening
• No high toxic effect
• taken by itself of accompanied by some other drug

Weitere ähnliche Inhalte

Was ist angesagt?

Immunosuppressants.pptx
Immunosuppressants.pptxImmunosuppressants.pptx
Immunosuppressants.pptxKedar Bandekar
 
Anticancer drug
Anticancer drugAnticancer drug
Anticancer drugPritom Roy
 
Immunosuppressant drugs by Pankaj Maurya
Immunosuppressant drugs by Pankaj Maurya Immunosuppressant drugs by Pankaj Maurya
Immunosuppressant drugs by Pankaj Maurya Pankaj Maurya
 
Immunopharmacology
ImmunopharmacologyImmunopharmacology
Immunopharmacologyalaa essa
 
Immunopharmacology
ImmunopharmacologyImmunopharmacology
ImmunopharmacologyDrx Burade
 
Immunomodulators
ImmunomodulatorsImmunomodulators
ImmunomodulatorsRahul B S
 
Platelet activating factors by aisha siddiqui
Platelet activating factors by aisha siddiquiPlatelet activating factors by aisha siddiqui
Platelet activating factors by aisha siddiquiAISHASID
 
Pharmacotherapy of tuberculosis
Pharmacotherapy of tuberculosisPharmacotherapy of tuberculosis
Pharmacotherapy of tuberculosisNaser Tadvi
 
Antifungal drugs
Antifungal drugs Antifungal drugs
Antifungal drugs Naser Tadvi
 
Cephalosporins & other β lactam antibiotics
Cephalosporins & other β lactam  antibioticsCephalosporins & other β lactam  antibiotics
Cephalosporins & other β lactam antibioticsFarazaJaved
 
Quinolones fluoroquinolones Pharmacology
Quinolones fluoroquinolones PharmacologyQuinolones fluoroquinolones Pharmacology
Quinolones fluoroquinolones PharmacologyKoppala RVS Chaitanya
 

Was ist angesagt? (20)

Immunosuppressants.pptx
Immunosuppressants.pptxImmunosuppressants.pptx
Immunosuppressants.pptx
 
Anticancer drug
Anticancer drugAnticancer drug
Anticancer drug
 
Immunosuppressant drugs by Pankaj Maurya
Immunosuppressant drugs by Pankaj Maurya Immunosuppressant drugs by Pankaj Maurya
Immunosuppressant drugs by Pankaj Maurya
 
Immunomodulators
ImmunomodulatorsImmunomodulators
Immunomodulators
 
Humira
HumiraHumira
Humira
 
Immunomodulators
ImmunomodulatorsImmunomodulators
Immunomodulators
 
Otezla
OtezlaOtezla
Otezla
 
Cotrimoxazole
CotrimoxazoleCotrimoxazole
Cotrimoxazole
 
Immunopharmacology
ImmunopharmacologyImmunopharmacology
Immunopharmacology
 
Antileprotic drugs
Antileprotic drugsAntileprotic drugs
Antileprotic drugs
 
Methotrexate
MethotrexateMethotrexate
Methotrexate
 
Immunopharmacology
ImmunopharmacologyImmunopharmacology
Immunopharmacology
 
Immunomodulators
ImmunomodulatorsImmunomodulators
Immunomodulators
 
Platelet activating factors by aisha siddiqui
Platelet activating factors by aisha siddiquiPlatelet activating factors by aisha siddiqui
Platelet activating factors by aisha siddiqui
 
Sulfonamides and cotrimoxazole
Sulfonamides and cotrimoxazoleSulfonamides and cotrimoxazole
Sulfonamides and cotrimoxazole
 
Pharmacotherapy of tuberculosis
Pharmacotherapy of tuberculosisPharmacotherapy of tuberculosis
Pharmacotherapy of tuberculosis
 
Antifungal drugs
Antifungal drugs Antifungal drugs
Antifungal drugs
 
Cephalosporins & other β lactam antibiotics
Cephalosporins & other β lactam  antibioticsCephalosporins & other β lactam  antibiotics
Cephalosporins & other β lactam antibiotics
 
Methotrexate.pptx
Methotrexate.pptxMethotrexate.pptx
Methotrexate.pptx
 
Quinolones fluoroquinolones Pharmacology
Quinolones fluoroquinolones PharmacologyQuinolones fluoroquinolones Pharmacology
Quinolones fluoroquinolones Pharmacology
 

Andere mochten auch

Adalimumab in Pediatric Crohn's Disease
Adalimumab in Pediatric Crohn's DiseaseAdalimumab in Pediatric Crohn's Disease
Adalimumab in Pediatric Crohn's Diseasemjavan2001
 
3d Stock Charts - Life 2.0 Data Visualization Panel
3d Stock Charts - Life 2.0 Data Visualization Panel3d Stock Charts - Life 2.0 Data Visualization Panel
3d Stock Charts - Life 2.0 Data Visualization PanelMelanie Swan
 
Core course lecture - Rheumatoid Arthritis
Core course lecture - Rheumatoid ArthritisCore course lecture - Rheumatoid Arthritis
Core course lecture - Rheumatoid ArthritisNES
 
Bioengineering: making life from scratch
Bioengineering: making life from scratchBioengineering: making life from scratch
Bioengineering: making life from scratchMelanie Swan
 
Single Use (Disposables) Presentation
Single Use (Disposables) PresentationSingle Use (Disposables) Presentation
Single Use (Disposables) PresentationAndy Rayner
 
Tracking Single-Use & Scale-Up Best Practices
Tracking Single-Use & Scale-Up Best PracticesTracking Single-Use & Scale-Up Best Practices
Tracking Single-Use & Scale-Up Best PracticesWPICPE
 
High Level Recombinant Protein Production In Insect Cell Culture
High Level Recombinant Protein Production In Insect Cell CultureHigh Level Recombinant Protein Production In Insect Cell Culture
High Level Recombinant Protein Production In Insect Cell CultureWPICPE
 
Cmc biologics pathway_draft8
Cmc biologics pathway_draft8Cmc biologics pathway_draft8
Cmc biologics pathway_draft8enarke
 
Biologic therapy for psoriasis
Biologic therapy for psoriasisBiologic therapy for psoriasis
Biologic therapy for psoriasisAhmed Amer
 
Rheumatoid arthritis for undergraduates
Rheumatoid arthritis for undergraduatesRheumatoid arthritis for undergraduates
Rheumatoid arthritis for undergraduatesDhananjaya Sabat
 
Rheumatoid Arthritis Power Point
Rheumatoid Arthritis Power PointRheumatoid Arthritis Power Point
Rheumatoid Arthritis Power Pointsteverluce
 

Andere mochten auch (20)

Cửa cuốn công nghệ úc
Cửa cuốn công nghệ úcCửa cuốn công nghệ úc
Cửa cuốn công nghệ úc
 
Adalimumab in Pediatric Crohn's Disease
Adalimumab in Pediatric Crohn's DiseaseAdalimumab in Pediatric Crohn's Disease
Adalimumab in Pediatric Crohn's Disease
 
3d Stock Charts - Life 2.0 Data Visualization Panel
3d Stock Charts - Life 2.0 Data Visualization Panel3d Stock Charts - Life 2.0 Data Visualization Panel
3d Stock Charts - Life 2.0 Data Visualization Panel
 
Adalimumab
AdalimumabAdalimumab
Adalimumab
 
World diabetes day
World diabetes dayWorld diabetes day
World diabetes day
 
Tauber
TauberTauber
Tauber
 
Diabetes And Kidney
Diabetes And KidneyDiabetes And Kidney
Diabetes And Kidney
 
target identefication
target identeficationtarget identefication
target identefication
 
Core course lecture - Rheumatoid Arthritis
Core course lecture - Rheumatoid ArthritisCore course lecture - Rheumatoid Arthritis
Core course lecture - Rheumatoid Arthritis
 
Bioengineering: making life from scratch
Bioengineering: making life from scratchBioengineering: making life from scratch
Bioengineering: making life from scratch
 
Single Use (Disposables) Presentation
Single Use (Disposables) PresentationSingle Use (Disposables) Presentation
Single Use (Disposables) Presentation
 
Biosimilars
BiosimilarsBiosimilars
Biosimilars
 
Tracking Single-Use & Scale-Up Best Practices
Tracking Single-Use & Scale-Up Best PracticesTracking Single-Use & Scale-Up Best Practices
Tracking Single-Use & Scale-Up Best Practices
 
Res update final
Res update finalRes update final
Res update final
 
High Level Recombinant Protein Production In Insect Cell Culture
High Level Recombinant Protein Production In Insect Cell CultureHigh Level Recombinant Protein Production In Insect Cell Culture
High Level Recombinant Protein Production In Insect Cell Culture
 
Cmc biologics pathway_draft8
Cmc biologics pathway_draft8Cmc biologics pathway_draft8
Cmc biologics pathway_draft8
 
Biologic therapy for psoriasis
Biologic therapy for psoriasisBiologic therapy for psoriasis
Biologic therapy for psoriasis
 
Drug discovery and development
Drug discovery and developmentDrug discovery and development
Drug discovery and development
 
Rheumatoid arthritis for undergraduates
Rheumatoid arthritis for undergraduatesRheumatoid arthritis for undergraduates
Rheumatoid arthritis for undergraduates
 
Rheumatoid Arthritis Power Point
Rheumatoid Arthritis Power PointRheumatoid Arthritis Power Point
Rheumatoid Arthritis Power Point
 

Ähnlich wie Adalimumab drug presentation

Biological therapy in rheumatic diseases
Biological therapy in rheumatic diseasesBiological therapy in rheumatic diseases
Biological therapy in rheumatic diseasesSamar Tharwat
 
what is new in tuberculosis
what is new in tuberculosiswhat is new in tuberculosis
what is new in tuberculosisPathKind Labs
 
Antibiotics 2015 in icu
Antibiotics 2015 in icuAntibiotics 2015 in icu
Antibiotics 2015 in icusamirelansary
 
Antibiotics 2015 in icu
Antibiotics 2015 in icuAntibiotics 2015 in icu
Antibiotics 2015 in icusamirelansary
 
18 march what is new in tuberculosis
18 march what is new in tuberculosis18 march what is new in tuberculosis
18 march what is new in tuberculosisPathKind Labs
 
Dermatotherapeutics - Systemic.pptx
Dermatotherapeutics -  Systemic.pptxDermatotherapeutics -  Systemic.pptx
Dermatotherapeutics - Systemic.pptxrashmikumari638900
 
Breast cancer case answer
Breast cancer case answerBreast cancer case answer
Breast cancer case answerABDULLAHALHAJI2
 
Pharmacotherapy of HIV management
Pharmacotherapy of HIV managementPharmacotherapy of HIV management
Pharmacotherapy of HIV managementsouravpharma
 
Management of anticancer toxicities
Management of anticancer toxicitiesManagement of anticancer toxicities
Management of anticancer toxicitiesjayaDadhich1
 
Pembrolizumab in advanced melanoma
Pembrolizumab in advanced melanomaPembrolizumab in advanced melanoma
Pembrolizumab in advanced melanomaRanjita Pallavi
 
Antifungals
AntifungalsAntifungals
Antifungalsmzabihi
 
Pathophysiology Chemotherapy of Cancer
Pathophysiology Chemotherapy of CancerPathophysiology Chemotherapy of Cancer
Pathophysiology Chemotherapy of Cancershaheen begum
 

Ähnlich wie Adalimumab drug presentation (20)

Introduction to chemotherapy
Introduction to chemotherapyIntroduction to chemotherapy
Introduction to chemotherapy
 
Treatment of ibd
Treatment of ibdTreatment of ibd
Treatment of ibd
 
Biological therapy in rheumatic diseases
Biological therapy in rheumatic diseasesBiological therapy in rheumatic diseases
Biological therapy in rheumatic diseases
 
IMiD drugs: multiple myeloma
IMiD drugs: multiple myelomaIMiD drugs: multiple myeloma
IMiD drugs: multiple myeloma
 
what is new in tuberculosis
what is new in tuberculosiswhat is new in tuberculosis
what is new in tuberculosis
 
Antibiotics 2015 in icu
Antibiotics 2015 in icuAntibiotics 2015 in icu
Antibiotics 2015 in icu
 
Antibiotics 2015 in icu
Antibiotics 2015 in icuAntibiotics 2015 in icu
Antibiotics 2015 in icu
 
18 march what is new in tuberculosis
18 march what is new in tuberculosis18 march what is new in tuberculosis
18 march what is new in tuberculosis
 
Dermatotherapeutics - Systemic.pptx
Dermatotherapeutics -  Systemic.pptxDermatotherapeutics -  Systemic.pptx
Dermatotherapeutics - Systemic.pptx
 
Breast cancer case answer
Breast cancer case answerBreast cancer case answer
Breast cancer case answer
 
Chair’s Take on Advances in Gynecologic Cancer Care: Exploring New Advances a...
Chair’s Take on Advances in Gynecologic Cancer Care: Exploring New Advances a...Chair’s Take on Advances in Gynecologic Cancer Care: Exploring New Advances a...
Chair’s Take on Advances in Gynecologic Cancer Care: Exploring New Advances a...
 
Pomalyst showcase 6.5
Pomalyst showcase 6.5Pomalyst showcase 6.5
Pomalyst showcase 6.5
 
Pharmacotherapy of HIV management
Pharmacotherapy of HIV managementPharmacotherapy of HIV management
Pharmacotherapy of HIV management
 
Management of anticancer toxicities
Management of anticancer toxicitiesManagement of anticancer toxicities
Management of anticancer toxicities
 
Antibiotics 2015 in icu
Antibiotics 2015 in icuAntibiotics 2015 in icu
Antibiotics 2015 in icu
 
Pembrolizumab in advanced melanoma
Pembrolizumab in advanced melanomaPembrolizumab in advanced melanoma
Pembrolizumab in advanced melanoma
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Antifungals
AntifungalsAntifungals
Antifungals
 
Pathophysiology Chemotherapy of Cancer
Pathophysiology Chemotherapy of CancerPathophysiology Chemotherapy of Cancer
Pathophysiology Chemotherapy of Cancer
 
27.antimicrobial drugs
27.antimicrobial drugs 27.antimicrobial drugs
27.antimicrobial drugs
 

Kürzlich hochgeladen

How to Add a New Field in Existing Kanban View in Odoo 17
How to Add a New Field in Existing Kanban View in Odoo 17How to Add a New Field in Existing Kanban View in Odoo 17
How to Add a New Field in Existing Kanban View in Odoo 17Celine George
 
How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17Celine George
 
In - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxIn - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxAditiChauhan701637
 
Practical Research 1 Lesson 9 Scope and delimitation.pptx
Practical Research 1 Lesson 9 Scope and delimitation.pptxPractical Research 1 Lesson 9 Scope and delimitation.pptx
Practical Research 1 Lesson 9 Scope and delimitation.pptxKatherine Villaluna
 
Human-AI Co-Creation of Worked Examples for Programming Classes
Human-AI Co-Creation of Worked Examples for Programming ClassesHuman-AI Co-Creation of Worked Examples for Programming Classes
Human-AI Co-Creation of Worked Examples for Programming ClassesMohammad Hassany
 
How to Add Existing Field in One2Many Tree View in Odoo 17
How to Add Existing Field in One2Many Tree View in Odoo 17How to Add Existing Field in One2Many Tree View in Odoo 17
How to Add Existing Field in One2Many Tree View in Odoo 17Celine George
 
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...Nguyen Thanh Tu Collection
 
5 charts on South Africa as a source country for international student recrui...
5 charts on South Africa as a source country for international student recrui...5 charts on South Africa as a source country for international student recrui...
5 charts on South Africa as a source country for international student recrui...CaraSkikne1
 
How to Solve Singleton Error in the Odoo 17
How to Solve Singleton Error in the  Odoo 17How to Solve Singleton Error in the  Odoo 17
How to Solve Singleton Error in the Odoo 17Celine George
 
Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.EnglishCEIPdeSigeiro
 
3.21.24 The Origins of Black Power.pptx
3.21.24  The Origins of Black Power.pptx3.21.24  The Origins of Black Power.pptx
3.21.24 The Origins of Black Power.pptxmary850239
 
Quality Assurance_GOOD LABORATORY PRACTICE
Quality Assurance_GOOD LABORATORY PRACTICEQuality Assurance_GOOD LABORATORY PRACTICE
Quality Assurance_GOOD LABORATORY PRACTICESayali Powar
 
AUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptxAUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptxiammrhaywood
 
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRADUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRATanmoy Mishra
 
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdfMaximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdfTechSoup
 
Prescribed medication order and communication skills.pptx
Prescribed medication order and communication skills.pptxPrescribed medication order and communication skills.pptx
Prescribed medication order and communication skills.pptxraviapr7
 
How to Make a Field read-only in Odoo 17
How to Make a Field read-only in Odoo 17How to Make a Field read-only in Odoo 17
How to Make a Field read-only in Odoo 17Celine George
 
How to Add a many2many Relational Field in Odoo 17
How to Add a many2many Relational Field in Odoo 17How to Add a many2many Relational Field in Odoo 17
How to Add a many2many Relational Field in Odoo 17Celine George
 
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptx
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptxPractical Research 1: Lesson 8 Writing the Thesis Statement.pptx
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptxKatherine Villaluna
 
The Singapore Teaching Practice document
The Singapore Teaching Practice documentThe Singapore Teaching Practice document
The Singapore Teaching Practice documentXsasf Sfdfasd
 

Kürzlich hochgeladen (20)

How to Add a New Field in Existing Kanban View in Odoo 17
How to Add a New Field in Existing Kanban View in Odoo 17How to Add a New Field in Existing Kanban View in Odoo 17
How to Add a New Field in Existing Kanban View in Odoo 17
 
How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17
 
In - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxIn - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptx
 
Practical Research 1 Lesson 9 Scope and delimitation.pptx
Practical Research 1 Lesson 9 Scope and delimitation.pptxPractical Research 1 Lesson 9 Scope and delimitation.pptx
Practical Research 1 Lesson 9 Scope and delimitation.pptx
 
Human-AI Co-Creation of Worked Examples for Programming Classes
Human-AI Co-Creation of Worked Examples for Programming ClassesHuman-AI Co-Creation of Worked Examples for Programming Classes
Human-AI Co-Creation of Worked Examples for Programming Classes
 
How to Add Existing Field in One2Many Tree View in Odoo 17
How to Add Existing Field in One2Many Tree View in Odoo 17How to Add Existing Field in One2Many Tree View in Odoo 17
How to Add Existing Field in One2Many Tree View in Odoo 17
 
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...
 
5 charts on South Africa as a source country for international student recrui...
5 charts on South Africa as a source country for international student recrui...5 charts on South Africa as a source country for international student recrui...
5 charts on South Africa as a source country for international student recrui...
 
How to Solve Singleton Error in the Odoo 17
How to Solve Singleton Error in the  Odoo 17How to Solve Singleton Error in the  Odoo 17
How to Solve Singleton Error in the Odoo 17
 
Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.
 
3.21.24 The Origins of Black Power.pptx
3.21.24  The Origins of Black Power.pptx3.21.24  The Origins of Black Power.pptx
3.21.24 The Origins of Black Power.pptx
 
Quality Assurance_GOOD LABORATORY PRACTICE
Quality Assurance_GOOD LABORATORY PRACTICEQuality Assurance_GOOD LABORATORY PRACTICE
Quality Assurance_GOOD LABORATORY PRACTICE
 
AUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptxAUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptx
 
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRADUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
 
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdfMaximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
 
Prescribed medication order and communication skills.pptx
Prescribed medication order and communication skills.pptxPrescribed medication order and communication skills.pptx
Prescribed medication order and communication skills.pptx
 
How to Make a Field read-only in Odoo 17
How to Make a Field read-only in Odoo 17How to Make a Field read-only in Odoo 17
How to Make a Field read-only in Odoo 17
 
How to Add a many2many Relational Field in Odoo 17
How to Add a many2many Relational Field in Odoo 17How to Add a many2many Relational Field in Odoo 17
How to Add a many2many Relational Field in Odoo 17
 
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptx
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptxPractical Research 1: Lesson 8 Writing the Thesis Statement.pptx
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptx
 
The Singapore Teaching Practice document
The Singapore Teaching Practice documentThe Singapore Teaching Practice document
The Singapore Teaching Practice document
 

Adalimumab drug presentation

  • 2. Introduction • human monoclonal antibody against TNF-alpha • C6428H9912N1694O1987S46 • organic chemical • produced by recombinant DNA technology using mammalian cell expression system • Adalimumab is used for treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and Crohn’s disease • immune system mediated diseases
  • 3. History • 1993 - BASF bioresearch and Cambridge Antibody • 3rd TNF inhibitor approved in United States • fully human monoclonal • initially discovered using CAT’s phage display technology and being named as D2E7 • BASF bioresearch Corporation – create • Abbott Laboratories – further manufacturing and marketing
  • 4. • 2008 - Food and Drug Administration (FDA) approved adalimumab as treatment of arthritis and Crohn’s disease • 2012 - FDA approved for treatment of ulcerative colitis • 2014 - generic drugs of adalimumab has been launched by other companies
  • 5. • sold under the trade name, Humira • rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, plaque psoriasis, Crohn’s disease • tumor necrosis factor-alpha (TNF- α) blocker
  • 6. How it works? • directly binding to TNF- α molecules in the blood and diseased tissue • blocks its interaction with the p55 and p75 cell surface TNF receptors • lyses surface TNF expressing cells in vitro • does not bind or inactivate lymphotoxin (TNF-beta) • Excess production of TNF-alpha - rapid growth of skin cells and damages to joint tissue • Adalimumab helps to stop the inflammatory cycle of psoriatic disease and prevent from causing the inflammation that result in psoriasis plaques.
  • 7. Prescription, Pharmacodynamics, Pharmacokinetics • prescribed by either itself or in combination with methotrexate • given after other medications has failed in treatment • safe to take it with topical treatments or pain relievers • Adult – decrease acute inflammation, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and serum cytokines (IL-6) • maximized with the maximum serum concentration • Tmax were 4.7 ± 1.6 µg/mL and 131 ± 56 hours • linear over the dose range of 0.5 to 10.0 mg/kg following a single intravenous dose
  • 8. efficacy of adalimumab • phase II randomized placebo-controlled trial evaluate 147 patients with psoriasis that at least 5% of their (BSA) infected and minimum 10 (PASI) • Patient had achieved the primary endpoint of PASI 75 or better as compared to 4% of the patients who received placebo. • phase II trial is to compare the efficacy of adalimumab to methotrexate (MTX) and placebo.
  • 9. • phase III trials were performed to directly compare the therapeutic efficacy, safety and tolerability and to provide greater body of data • 80patients given adalimumab, 36% patients given methotrexate and 19% patients given placebo achieving a PASI 75 response rate at a given time • (PGA) score :73% in adalimumab, 30% in methotrexate and 11% in placebo • second phase III trials was to examine the short- and long-term efficacy of adalimumab as monotherapy against placebo • treatment with 40mg adalimumab every other week • efficacy of adalimumab is sustainable.
  • 10. • high dose in phase II - Adverse reaction of pain with injection • headache, nausea, elevated triglycerides, cough, sinus congestion, and fatigue • no increase of serious adverse events in phase III trials • recommended dose of 40 mg every other week, and the higher dose of 40 mg weekly, either alone or in combination with methotrexate or other DMARDs • short- and long-term safety, tolerability and substantial efficacy
  • 11. Risk • developing severe and even fatal infections • Tuberculosis may be caused by a new infection or by reactivation of a previous infection • tumor necrosis factor (TNF) blocker - develop Lymphoma and other types of cancer such as hepatosplenic T-cell lymphoma (HSTCL) • attempt a TB skin test before taking Adalimumab • positive result should begin treatment for TB • negative result should also be monitored for signs of TB while using adalimumab
  • 12. Precautions • Should not drive - dizziness or vision changes • avoid contact with people who have colds or infections • should not do any activities that may cause bruising or injury • should not breastfeed
  • 13. Side Effects Common side effect • back pain, headache, redness or swelling at injection site • mild stomach pain, nausea or runny nose Severe side effect • rash, itching, difficulty in breathing, swelling of lips or tongue, blood in urine, burning, numbness, chest pain, fainting, blistered, peeling skin, swelling of ankles, diarrhoea or vomit.
  • 14. Overdose • still unclear • does not show toxic effects in clinical trials
  • 15. Challenges • target specific drugs • specialized drug for individual • competition of new generic drugs • Amgen for patenting rights
  • 16. Conclusion • fully human monoclonal anti-TNF antibody drug • treat inflammation and chronic skin condition • Efficacy of adalimumab is sustainable • side effect isn’t life threatening • No high toxic effect • taken by itself of accompanied by some other drug